Susan Alpert

Chief Regulatory Officer at Accelmed

Dr. Alpert began working with Accelmed in 2011. Previously, she had served as Corporate Senior Vice President for Global Regulatory Affairs at Medtronic and Vice President of Regulatory Science at C.R. Bard. Prior to entering private industry, Dr. Alpert held a variety of management positions at the US FDA covering drugs, devices and radiological health, and foods. Notably, Dr. Alpert was Director of the Office of Device Evaluation from 1993-1999. Susan remains a member and was formerly Chair of the Board of the Society for Women’s Health Research, and has also served on the Board of the Food Drug Law Institute, the Medical Technology Leadership Forum, and Women Business Leaders of the U.S. Health Care Industry Foundation (WBL). She is also a Fellow and former Chair of the Regulatory Affairs Professional Society. Susan served on the Executive Committee of the Clinical Trials Transformation Initiative and served two terms on the Board of the Minnesota International Center.

Dr. Alpert completed her undergraduate degree at Barnard College, Columbia University in New York City, and is a Pediatric Infectious Disease clinician with a Ph.D. in Medical Microbiology from NYU and an M.D. from the University of Miami, who has practical experience in laboratory research and clinical trials.

Timeline

  • Chief Regulatory Officer

    Current role